These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23038789)

  • 21. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.
    Brunet-Bernard A; Maréchaux S; Fauchier L; Guiot A; Fournet M; Reynaud A; Schnell F; Leclercq C; Mabo P; Donal E
    Am J Cardiol; 2014 Jun; 113(12):2045-51. PubMed ID: 24793667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long term results of cardiac resynchronisation therapy for patients with severe heart failure].
    Bulava A; Lukl J; Hutyra M; Marek D
    Vnitr Lek; 2007 Nov; 53(11):1153-63. PubMed ID: 18277624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy.
    Rickard J; Bassiouny M; Tedford RJ; Baranowski B; Spragg D; Cantillon D; Varma N; Wilkoff BL; Tang WH
    Am J Cardiol; 2015 Jan; 115(1):82-5. PubMed ID: 25491007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy in mild heart failure.
    Linde C
    Europace; 2009 Nov; 11 Suppl 5():v72-6. PubMed ID: 19861394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
    Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D
    Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure.
    Francia P; Balla C; Ricotta A; Uccellini A; Frattari A; Modestino A; Borro M; Simmaco M; Salvati A; De Biase L; Volpe M
    Int J Cardiol; 2011 Dec; 153(3):306-10. PubMed ID: 20863582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
    Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.